Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | +0.14% | +29.68% |
2023 | Nestle Reportedly May Sell Peanut Allergy Therapy to Stallergenes | CI |
2023 | Stallergenes Greer Ltd Initiates European Paediatric Phase III Study with Staloral Birch | CI |
1st Jan change | Capi. | |
---|---|---|
+29.68% | 0 | |
+19.50% | 80.67B | |
+13.63% | 9.17B | |
-15.14% | 4.86B | |
+45.17% | 4.55B | |
+15.70% | 4.34B | |
+16.79% | 2.38B | |
-26.13% | 2.2B | |
+15.73% | 2.1B | |
-40.52% | 1.86B |
- Stock Market
- Equities
- STAGR Stock
- News Stallergenes Greer
- Stallergenes Greer plc Announces Resignation of Peter Bühler as Chief Financial Officer Effective April 28, 2017